Xcout Intel
Rejuvenate Bio Inc
Rejuvenate Bio, Inc. is a biotechnology company founded in 2019 and headquartered in San Diego, United States, specializing in innovative gene therapy applications.
Subscribe to see Rejuvenate Bio Inc’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Rejuvenate Bio Inc at a glance
Rejuvenate Bio Inc is a biotech company headquartered in United States. It has raised at least $34M across the 2 funding rounds on record. Its most recent funding round raised $19.5M in June 2026. Xcout tracks 7 named people at Rejuvenate Bio Inc, including Daniel Oliver (CEO, Co-Founder).
Rejuvenate Bio Inc leadership
- Daniel OliverCEO, Co-Founder
- Deborah AscheimChief Medical Officer
- Noah DavidsohnCSO, Co-Founder
- George ChurchCo-Founder and SAB
- Daniel OliverExecutive Officer
- Noah DavidsohnExecutive Officer
1 more named person on record for Rejuvenate Bio Inc, with roles, board committees and tenure — see the full roster →
Rejuvenate Bio Inc funding rounds
At least $34M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $19.5M | — | |
| Series A | $14.6M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Rejuvenate Bio Inc competitors
A few of Rejuvenate Bio Inc's closest competitors — see the full list of competitors and alternatives →
Kriya Therapeutics, Inc. is a fully integrated biopharmaceutical company with operational footprints in Redwood City, California, and Research Triangle Park, North Carolina. The company develops novel gene therapies to address diverse diseases.
ReCode Therapeutics is a clinical-stage genetic medicines company headquartered in Menlo Park, California, and Durham, North Carolina. The company leverages proprietary delivery systems to power a new class of disease-modifying genetic therapies.
Ray Therapeutics, Inc. is a privately held optogenetic gene therapy company headquartered in Berkeley, California. The company focuses on reimagining vision through innovative genetic treatments and novel therapeutic solutions.
Verve Therapeutics, Inc. is a biotechnology company headquartered in Boston, Massachusetts, dedicated to pioneering single-course gene editing medicines for cardiovascular disease.
Gemma Labs Inc. (GEMMABio) is a biotechnology company that develops gene therapies for rare diseases using next-generation AAV technology. The company focuses on programs targeting motor neuron disorders, skeletal conditions, and cardiomyopathies to serve the rare disease community.
Get Rejuvenate Bio Inc's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Rejuvenate Bio Inc in Xcout Intel
- 7 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access